𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activation of conflicting responses in Parkinson's disease: evidence for degrading and facilitating effects on response time

✍ Scribed by Scott A. Wylie; Julie C. Stout; Theodore R. Bashore

Book ID
113818029
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
177 KB
Volume
43
Category
Article
ISSN
0028-3932

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effects of cisapride on plasma L-dop
The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease
✍ Walter Diaz Neira; Vicenta Sanchez; Maria Angeles Mena; Dr. Justo Garcia de Yebe πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 428 KB πŸ‘ 1 views

Cisapride (CIS) is a prokinetic agent that increases gastrointestinal motility in normal individuals and improves constipation in Parkinson's disease (PD). We studied the effects of CIS on the clinical response and the peripheral pharmacokinetics of orally administered L-dopa given to patients with

Effect of entacapone, a COMT inhibitor,
Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease
✍ V. V. MyllylΓ€; K. A. Sotaniemi; A. Illi; K. Suominen; T. KerΓ€nen πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 563 KB

In an open, randomised, cross-over study we investigated the effect of a single 200 mg oral dose of entacapone, a novel catechol-O-methyltransferase (COMT) inhibitor, on the pharmacokinetics and metabolism of levodopa/carbidopa, and on the cardiovascular responses (blood pressure and pulse rate vari